Innoveren Scientific Inc.
IVRN
$0.0002
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | 78.25% | 131.13% | 46.29% | -99.88% | -288.58% |
| Total Depreciation and Amortization | -60.98% | -42.86% | -50.00% | 105.00% | 1,266.67% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -99.35% | -166.55% | -51.47% | 218.01% | 425.68% |
| Change in Net Operating Assets | -32.86% | 284.01% | 160.38% | 201.17% | 287.17% |
| Cash from Operations | -10.66% | 78.48% | 59.06% | 88.84% | 76.38% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 173,740.00% | -- | -- | -- | -- |
| Total Debt Issued | -100.00% | -90.97% | -- | -96.15% | 128.60% |
| Total Debt Repaid | 79.13% | 100.00% | -189.67% | 100.00% | -335.61% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -104.21% | -89.93% | -57.71% | -90.98% | 646.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 5,875.00% | 65.00% | -52.86% | 82.69% | 99.24% |